0.9297
-0.0003
(-0.03%)
As of 10:55:43 AM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
CHONG NGAI HANG VICTOR Officer | Purchase | Nov 1, 2024 | 100,000 |
DEIGNAN CHARLES A Chief Financial Officer | Sale | Jan 19, 2024 | 384,662 |
GIBNEY ANTHONY S. Director | Purchase | Apr 18, 2024 | 100,000 |
HUMPHRIES WILLIAM DOUGLAS Director | Conversion of Exercise of derivative security | Sep 22, 2023 | 51,040 |
HUTSON NANCY J Director | Purchase | Oct 3, 2023 | 93,000 |
LASEZKAY GEORGE M Chief Executive Officer | Sale | Jan 19, 2024 | 466,577 |
THORP CLAY B. Director | Purchase | Sep 25, 2023 | 3,585,560 |
WHITMORE BRADFORD T Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 7, 2024 | 6,845,190 |
YERXA BENJAMIN R Director | Purchase | May 15, 2024 | 17,957 |
Related Tickers
ADIL Adial Pharmaceuticals, Inc.
0.9550
-2.36%
LPTX Leap Therapeutics, Inc.
2.3600
+9.77%
PSTV Plus Therapeutics, Inc.
1.2300
+1.65%
IPSC Century Therapeutics, Inc.
0.9015
+0.17%
TCBP TC Biopharm (Holdings) Plc
0.3204
-1.11%
RLYB Rallybio Corporation
0.8820
+0.23%
PASG Passage Bio, Inc.
0.6050
-0.17%
GLYC GlycoMimetics, Inc.
0.2659
-2.33%
KPTI Karyopharm Therapeutics Inc.
0.6861
-1.97%
ACET Adicet Bio, Inc.
0.9101
-1.27%